MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0338519

Медицинская библиотека · PloS one · 2026

Elevated mortality and upregulated SARS-CoV-2-associated pathways in innate and adaptive immune cells from individuals with Down syndrome.

Victorino Daniella Balduino, Malheiros Jackeline Moraes, Ten-Caten Felipe, Cardoso Betta Victor Hugo, Barbosa Felipe Farinha Saad, Ghneim Khader, Coirada Fernanda Caroline, Bruno Fernanda Romano, de Medeiros Giuliana Xavier, Silveira Cassia, Gavegnano Christina, Balderas Robert, Brandao Ana Claudia, Yang Edward, Nakaya Helder, Wagner Gabriela A, Covolan Luciene, Pereira Ribeiro Susan

СтатьяПеревод в очереди

Аннотация

Trisomy 21 increases the risk of severe outcomes and mortality in hospitalized individuals with Down syndrome (DS) following SARS-CoV-2 infection. Using data from the Brazilian Epidemiological Surveillance Information System Influenza (SIVEP-Gripe), we analyzed 102,767 hospitalized COVID-19 patients (1,115 DS and 101,652 non-DS, NDS). DS patients had a higher prevalence of comorbidities and required ventilatory support, ICU admission, and intubation more frequently than NDS patients (p < 0.001). Mortality was 4.5 times higher in DS patients aged 0-30 years (26.3% vs. 5.9%, p < 0.001) and remained 2.22 times higher after adjusting for comorbidities. DS patients over 30 years also exhibited a 22% increase in mortality (PR 1.22, p < 0.001). Gene expression analysis of pre-pandemic monocytes and T cells from DS individuals revealed upregulated pathways linked to SARS-CoV-2 infection, including interferon signaling and cytokine interactions. This baseline immune dysregulation may contribute to severe COVID-19 outcomes in DS patients. Identifying these altered pathways could inform targeted therapeutic strategies to improve immune homeostasis and clinical outcomes. To the best of our knowledge, this is the first study integrating nationwide clinical outcomes with pre-pandemic immune transcriptomic data to mechanistically explain the heightened COVID-19 severity in individuals with DS.

Для цитирования: Victorino Daniella Balduino, Malheiros Jackeline Moraes, Ten-Caten Felipe, Cardoso Betta Victor Hugo, Barbosa Felipe Farinha Saad, Ghneim Khader, Coirada Fernanda Caroline, Bruno Fernanda Romano, de Medeiros Giuliana Xavier, Silveira Cassia, Gavegnano Christina, Balderas Robert, Brandao Ana Claudia, Yang Edward, Nakaya Helder, Wagner Gabriela A, Covolan Luciene, Pereira Ribeiro Susan. Elevated mortality and upregulated SARS-CoV-2-associated pathways in innate and adaptive immune cells from individuals with Down syndrome.. PloS one. 2026. DOI: 10.1371/journal.pone.0338519.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.